Bright Minds Biosciences (DRUG) Skyrockets with Private Placement Announcement

Author's Avatar
Oct 18, 2024

Bright Minds Biosciences (DRUG, Financial) has seen its stock price surge dramatically, rising 52 times over the past five trading days and setting a new all-time high. Recently, the stock soared over 165%, reaching $57.72.

The surge follows the company's announcement of a private placement of common shares at $21.70 each. This non-brokered private placement also includes the issuance of prepaid company warrants (PFWs) priced at $21.699 each. The total gross proceeds from these offerings amount to $35 million.

The company retains the discretion over the number of shares and PFWs to be issued. The stock offering and the warrant issuance together comprise the financing package.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.